Webinars and Sponsored Roundtables — Register Now
Tuesday, April 28, 2026, 12:00 PM–1:00 PM ET
Discover how next-day comprehensive genomic profiling (CGP) is possible with the Oncomine Comprehensive Assay Plus on the Genexus System—delivering both speed and accuracy.
Webinar presenters Jane Bayani, MHSc, PhD, Assistant Professor and Co-Director, Diagnostic Development, Ontario Institute for Cancer Research, Canada, and Nicola Normanno, MD, Scientific Director, IRCCS Romagnolo Institute for the Study of Tumors, Italy, and Morten Grauslund, PhD, Molecular Biologist, Department of Pathology, Rigshospitalet/Copenhagen University Hospital, Copenhagen, Denmark.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
CAP TODAY does not endorse any of the products or services named within. The webinar is made possible by a special educational grant from Thermo Fisher Scientific. For Research Use Only. Not for use in diagnostic applications.
Thursday, April 30, 2026, 11:00 AM–12:00 PM ET
Hear an expert discuss how Memorial Sloan Kettering Cancer Center (MSKCC) is utilizing
the oncoReveal® Nexus 21-gene panel to redefine turnaround time and actionable insights
in cancer care. Dr. Ewalt shares a perceptive look at the clinical need for rapid, front-line NGS sequencing, and how a unique, purpose built targeted NGS panel (Pillar Biosciences’ oncoReveal Nexus 21 gene Panel) was developed, validated and implemented clinically by Memorial Sloan Kettering Cancer Center (MSK-REACT) to complement their current comprehensive genomic profiling (CGP) approach.
Webinar presenter Mark Ewalt, MD, Associate Medical Director for Laboratory Operations for Diagnostic Molecular Pathology in the Molecular Diagnostics Service, Department of Pathology and Laboratory Medicine, MSKCC.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
CAP TODAY does not endorse any of the products or services named within. The webinar is made possible by a special educational grant from Pillar Biosciences.
Thursday, May 28, 2026, 1:00–2:00 PM ET
This session is designed to improve understanding and application of recent updates to synoptic pathology reporting protocols such as the latest Reporting Template for Reporting Results of Biomarker Testing of Specimens from Patients with Carcinoma of the Breast. These changes reflect evolving clinical guidelines that directly influence diagnostic accuracy and treatment selection in breast cancer care.
Webinar presenters Thaer Khoury, MD, FCAP, Chair, Pathology and Laboratory Medicine, Roswell Park Comprehensive Cancer Cente, and Colin Murphy, CEO of mTuitive.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Subspecialties
Interactive Product Guides
Product Spotlight
Abbott
| Company | Abbott |
|---|---|
| Name of analyzer | CELL-DYN Emerald 22 Autoloader |
| Contact | James Pickering |
| City, State | Lake Forest, IL |
| Phone | 800-323-9100 |
| Website | |
| Analyzer application | diagnostic use |
| Dimensions of analyzer (H × W × | 16.1 × 19.7 × 17 in./— |
| Country where analyzer was | U.S./Germany |
| First year analyzer was sold in U.S./Approximate No. of units installed in U.S.* | 2019/32 |
| First year analyzer sold outside | —/351 |
| Foreign locations where company | Brazil, Canada, Italy, Japan, Saudi Arabia, Spain, U.K., Vietnam, more (installed in the aforementioned countries) |
| Human languages (other than | French, Italian, German, Spanish, more |
| Analyzer list price | $75, 000 |
| • Analyzer acquisition options | purchase, trade in, lease, reagent rental agreement |
| Training included with purchase/Total time for basic training per operator | 15 min. weekly; ~10 min. quarterly |
| • Follow-up training available | yes (extra charge) |
| Parameters that analyzer tests and reports | %&# eosinophils, %&# lymphocytes, %&# monocytes, %&# neutrophils, %&# basophils, Hb, Hct, MCH, MCHC, MCV, PLT, RBC, WBC |
| Types of testing FDA cleared or approved for analyzer | — |
| Types of body fluids FDA cleared or approved for analysis on analyzer | — |
| Analytical measurement range for body fluid | — |
| Precision for body fluid | — |
| Accuracy for body fluid | — |
| Automated differential performed for body fluids | — |
| Tests available for research use only | — |
| Differential methods used | Uni-Flow optical technology |
| Analytical measurement range: • WBC count/RBC count | WBC: 0.4–90 K/µL/RBC: 1.2–8.3 M/µL |
| Precision: • WBC count/RBC count | WBC: 3.2% CV/RBC: 2.0% CV |
| Accuracy: • WBC count/RBC count | — |
| Interfering substances: • WBC/RBC | cryoglobulin, cryofibrinogen, heparin, monoclonal proteins, NRBCs, platelet clumping, unlysed RBCs, more/cryoglobulin, cryofibrinogen, giant platelets, high WBC count (>50, 000 K/µL), autoagglutination, clotting, more |
| • Hemoglobin/Platelets | carboxyhemoglobin (>10%), cryoglobulin, cryofibrinogen, in vivo hemolysis, heparin, hyperbilirubinemia, more/cryoglobulin, cryofibrinogen, in vivo and in vitro hemolysis, microcytic RBCs, RBC inclusions, clotting, heparin, more |
| • Hematocrit/Reticulocytes | cryoglobulin, cryofibrinogen, giant platelets, high WBC count (>50, 000 K/μL), hyperglycemia (>600 mg/dL), autoagglutination, clotting, in vitro hemolysis, microcytic RBCs/— |
| • Automated differential | platelet aggregates, erythroblasts, small lymphocytes, immature cells, resistant RBCs, more |
| Throughput: max. CBCs per hour/Max. CBCs with differentials per hour | 40/40 |
| • Max. No. of slides processed per hour if stainer included | — |
| FDA-cleared or -approved sample container types (besides potassium EDTA) | none |
| Min. specimen volume open mode/Closed mode/Microsample capability | 21 μL/21 μL/no |
| Types of patient data archived/Max. No. of archived patient data accessible when analyzer online | patient demographics, previous test results, graphics, more (customizable)/300, 000 on USB, 1, 000 records with histograms on internal memory |
| Analyzer performs delta checks | no |
| Parameters for which flags may appear | dispersed data alerts, suspect parameter flags, count invalidation flags |
| Analyzer recognizes and holds test results | yes, for follow-up, confirmatory testing, and potential test rerun (parameters for flags to hold samples defined by vendor) |
| Scattergram display uses cell-specific color | yes |
| Histogram display uses color with thresholds | yes |
| LIS interface formats supported | proprietary (analyzer or vendor specific) |
| • Middleware interface | yes (can use company’s middleware or third-party middleware or connect directly to LIS) |
| • Information transferred to LIS via middleware or LIS interface | numeric results, flagged results |
| Analyzer transmits LOINC codes for results to LIS or middleware | no |
| Lab automation system or workcells to which analyzer has a direct interface | none |
| Barcode symbologies read on specimen tube | Codabar, Code 39, Code 128, Interleaved 2 of 5, Code 39 Full ASCII, Code 93, EAN8, EAN13, EAN128, IATA, more |
| • Analyzer allows barcode placement per CLSI standard Auto02-A2 | no |
| No. of onboard reagents required for standard specimen analysis | 2 |
| • Reagents ready to use/Reagent tracking method | yes/barcode reader |
| Onboard diagnostics for troubleshooting | no |
| • Manufacturer can perform diagnostics via remote access | no |
| Warranty provided/Cost of annual service contract (24 h/7 d) | one-year warranty/variable |
| Notes | †also marketed by distributors |